Abstract
Invasive fungal infections, particularly those caused by Candida species, are not uncommon in critically ill patients and are associated with considerable morbidity and mortality. Diagnosis and management of these infections can be challenging. In this review, we will briefly discuss recent epidemiological data on invasive candidiasis and current diagnostic approaches before concentrating on antifungal treatments.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Antifungal Agents / pharmacology
-
Antifungal Agents / therapeutic use*
-
Candida albicans / pathogenicity
-
Candidiasis / diagnosis
-
Candidiasis / drug therapy*
-
Disease Management*
-
Fluconazole / pharmacology
-
Fluconazole / therapeutic use
-
Humans
-
Intensive Care Units*
-
Triazoles / pharmacology
-
Triazoles / therapeutic use
Substances
-
Antifungal Agents
-
Triazoles
-
Fluconazole